Teva Pharmaceutical Industries Ltd (TEVA) Stock Analysis
Verdict: HOLD
Technical breakout and consistent earnings beats signal a turnaround, but aggressive insider selling near $36 caps the immediate upside.
Investment score: 64/100
Analysis as of
Is Teva Pharmaceutical Industries Ltd stock worth reviewing? The TradeMates thesis
Strong technicals and earnings momentum vs. heavy insider selling and structural debt.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 50/100 (weight 15%)
- Technical Momentum: 85/100 (weight 15%)
- Earnings Quality: 90/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 75/100 (weight 10%)
- Risk-Adjusted Return: 60/100 (weight 15%)
Teva Pharmaceutical Industries Ltd opportunities and risks
What speaks for TEVA
- Acceleration of Specialty Portfolio Revenue
What speaks against TEVA
- Stagnant Revenue Growth Profile
Peers and competitors
- TEVA.TA
- CAVG
- SLGL
- INCR.TA
- MDWD
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| TEVA | 26.0x | 2.4x | 16.5x | 52.0% | 9.0% | 4.6% |
| CAVG | 12916.0x | 33.8x | 313.5x | 99.4% | 10.2% | 0.0% |
| SLGL | n/a | 11.2x | n/a | 100.0% | -5.7% | 0.0% |
| MDWD | n/a | 10.8x | n/a | 19.6% | -180.3% | -15.6% |
| Peer median | n/a | 11.2x | n/a | 99.4% | -5.7% | 0.0% |
Frequently asked questions about Teva Pharmaceutical Industries Ltd (TEVA)
Is TEVA stock a good investment?
The TradeMates model rates Teva Pharmaceutical Industries Ltd as HOLD with an investment score of 64/100. Strong technicals and earnings momentum vs. heavy insider selling and structural debt. This is algorithmic model output, not personal investment advice.
Is TEVA stock a buy?
The TradeMates model verdict for TEVA is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.